標題: Titlebook: Bone marrow stem cell therapy for stroke; Kunlin Jin,Xunming Ji,Qichuan Zhuge Book 2017 Springer Nature Singapore Pte Ltd. 2017 bone marro [打印本頁] 作者: 可憐 時間: 2025-3-21 18:25
書目名稱Bone marrow stem cell therapy for stroke影響因子(影響力)
書目名稱Bone marrow stem cell therapy for stroke影響因子(影響力)學科排名
書目名稱Bone marrow stem cell therapy for stroke網(wǎng)絡(luò)公開度
書目名稱Bone marrow stem cell therapy for stroke網(wǎng)絡(luò)公開度學科排名
書目名稱Bone marrow stem cell therapy for stroke被引頻次
書目名稱Bone marrow stem cell therapy for stroke被引頻次學科排名
書目名稱Bone marrow stem cell therapy for stroke年度引用
書目名稱Bone marrow stem cell therapy for stroke年度引用學科排名
書目名稱Bone marrow stem cell therapy for stroke讀者反饋
書目名稱Bone marrow stem cell therapy for stroke讀者反饋學科排名
作者: 莊嚴 時間: 2025-3-21 22:54 作者: 允許 時間: 2025-3-22 03:21 作者: propose 時間: 2025-3-22 04:47
Interaction of Bone Marrow Stem Cells with Other Cells,nderlying functional recovery after stroke remain unclear. Clearly, BMSCs benefit the neurological dysfunction in either direct or indirect methods through the interaction with other cells. In this chapter, we review the direct and indirect interactions of transplanted BMSCs with HSCs, immune cells,作者: 觀點 時間: 2025-3-22 10:13 作者: 五行打油詩 時間: 2025-3-22 16:01 作者: Admonish 時間: 2025-3-22 18:51
Endothelial Progenitor Cell Therapy in Stroke,ental animal models and clinical trials. In this review, we discussed the characteristics of EPCs in the stroke therapy. We summarized the effect of EPCs on the treatment of cerebrovascular diseases including ischemic and hemorrhagic stroke, moyamoya disease, and vascular tumor, etc. Although the mo作者: Infantry 時間: 2025-3-22 23:11
Co-transplantation Strategies and Combination Therapies for Stroke,cidence of stroke increases significantly with age both in men and women with incidence rates accelerating above 70 years. Since stroke afflicts mostly the elderly comorbid patients, it is highly desirable to test the efficacy of cell therapies in an appropriate animal stroke model. All monotherapeu作者: 散布 時間: 2025-3-23 03:29
Modification of Bone Marrow Stem Cells for Homing and Survival During Cerebral Ischemia,sability worldwide. Various stem cells from bone marrow, such as mesenchymal stem cells (MSCs), hematopoietic stem cells (HSCs), and endothelial progenitor cells (EPCs), have shown therapeutic potential for stroke. Concomitant with these exciting findings are some fundamental bottlenecks that must b作者: APO 時間: 2025-3-23 08:37
Clinical Studies of Bone Marrow-Derived Stem Cell Therapy in Stroke Patients,tics and endovascular thrombectomy can reduce stroke disability; however, only a small minority of patients receive these treatments. Once the neurological deficits are established, there are few options for recovery. In recent years, extensive cell therapy preclinical research has demonstrated a ne作者: 大罵 時間: 2025-3-23 11:08 作者: 異端邪說下 時間: 2025-3-23 14:07 作者: mighty 時間: 2025-3-23 22:06 作者: 難理解 時間: 2025-3-23 23:03 作者: 概觀 時間: 2025-3-24 06:15 作者: HAVOC 時間: 2025-3-24 08:15 作者: encomiast 時間: 2025-3-24 11:56 作者: agenda 時間: 2025-3-24 18:05 作者: 字形刻痕 時間: 2025-3-24 22:38
https://doi.org/10.1007/978-1-349-26998-3s. More understanding of the underlying mechanisms for MSC therapy is essential for improving the therapeutic efficacy and ameliorating or avoiding side effects. In this chapter, we reviewed progress in the field that includes the following aspects: (1) the neurotrophic and immunomodulatory function作者: capillaries 時間: 2025-3-25 01:26 作者: Ataxia 時間: 2025-3-25 06:04
Lloyd George and the Lost Peaceental animal models and clinical trials. In this review, we discussed the characteristics of EPCs in the stroke therapy. We summarized the effect of EPCs on the treatment of cerebrovascular diseases including ischemic and hemorrhagic stroke, moyamoya disease, and vascular tumor, etc. Although the mo作者: Flirtatious 時間: 2025-3-25 11:25 作者: entrance 時間: 2025-3-25 13:26
Zhiguo Shi,Chaojie Gu,Shibo He,Kang Husability worldwide. Various stem cells from bone marrow, such as mesenchymal stem cells (MSCs), hematopoietic stem cells (HSCs), and endothelial progenitor cells (EPCs), have shown therapeutic potential for stroke. Concomitant with these exciting findings are some fundamental bottlenecks that must b作者: 入會 時間: 2025-3-25 16:49 作者: dictator 時間: 2025-3-25 21:15 作者: 退潮 時間: 2025-3-26 03:58 作者: Esophagus 時間: 2025-3-26 04:30
Characteristic Service Stresses,ic health problem, and it has created heavy public and personal financial burdens. By contrast to the severity of stroke in public health, the treatment of stroke is very limited. Currently, a clot-dissolving drug (rtPA) is the only treatment available for ischemic stroke. The majority of stroke pat作者: 支架 時間: 2025-3-26 10:44
Xu Chengzhong,Francis C. M. Laucal processes of transplanted stem cells in vivo. Further means of monitoring the transplanted cells safely, noninvasively, and longitudinally would contribute to the understanding of the underlying stem cell therapeutic mechanism. In this chapter, we describe the state-of-the-art methods of monitor作者: 走調(diào) 時間: 2025-3-26 15:28 作者: VOC 時間: 2025-3-26 18:57
978-981-10-9741-6Springer Nature Singapore Pte Ltd. 2017作者: 嘮叨 時間: 2025-3-26 21:27 作者: 切掉 時間: 2025-3-27 04:24 作者: 考博 時間: 2025-3-27 07:18 作者: Gratuitous 時間: 2025-3-27 10:22
https://doi.org/10.1057/9780230511484tem/progenitor cells (HSPC) are the most frequently cells used in preclinical and clinical neurorestorative studies in stroke therapy. Therefore co-transplantation of BM MSCs with other cells may be a better strategy to improve microenvironment, make the grafting more efficient, and improve function作者: Alpha-Cells 時間: 2025-3-27 15:25 作者: 笨拙的我 時間: 2025-3-27 19:14 作者: Limousine 時間: 2025-3-27 23:23 作者: 尋找 時間: 2025-3-28 05:45
Co-transplantation Strategies and Combination Therapies for Stroke,tem/progenitor cells (HSPC) are the most frequently cells used in preclinical and clinical neurorestorative studies in stroke therapy. Therefore co-transplantation of BM MSCs with other cells may be a better strategy to improve microenvironment, make the grafting more efficient, and improve function作者: 信條 時間: 2025-3-28 06:48 作者: 翻布尋找 時間: 2025-3-28 12:51 作者: charisma 時間: 2025-3-28 14:37 作者: NATAL 時間: 2025-3-28 20:51 作者: 葡萄糖 時間: 2025-3-29 02:20 作者: Prostatism 時間: 2025-3-29 05:53
Book 2017information on human clinical trials and animal models of stroke. In addition, it reviews the optimal conditions of transplantation for stroke therapy and potential mechanisms underlying transplanted cell-mediated functional recovery after stroke. As the first book to focus on BMSC therapy for strok作者: 智力高 時間: 2025-3-29 08:55 作者: 鋼筆尖 時間: 2025-3-29 12:17
https://doi.org/10.1007/978-1-349-26998-3utcome; (3) how autologous MSCs derived from diseased patients may affect the therapeutic effects; (4) different sources of MSCs and comparison of their effects in therapy; and (5) time of transplantation and the delivery methods.作者: 繁重 時間: 2025-3-29 17:19 作者: Exterior 時間: 2025-3-29 22:34
Epidemiology and Public Health Importance,cell number, delivery sites of cells, and transplantation time on the stroke outcome. In addition, we also discuss the efficacy and safety of bone marrow stem cell transplantation for stroke treatment.作者: 異端 時間: 2025-3-30 03:14 作者: 瘙癢 時間: 2025-3-30 07:47 作者: 最小 時間: 2025-3-30 11:55
Modification of Bone Marrow Stem Cells for Homing and Survival During Cerebral Ischemia,ansplantation. In this chapter, strategies such as gene modification, hypoxia/growth factor preconditioning, and biomaterial-based methods to improve cell survival and homing are summarized, and the potential strategies for their future application are also discussed.作者: 小故事 時間: 2025-3-30 12:55 作者: pellagra 時間: 2025-3-30 17:01
Potential Mechanisms of Transplanted Cell-Mediated Recovery After Stroke,ional integration with the existing brain circuitry; (2) neuroprotection through trophic factor secretion; (3) increased formation of new vasculature; (4) structural and functional changes to the brain; and (5) recruitment of endogenous progenitors.
